Apogee Therapeutics, Inc. (APGE)
Data as of , from SEC Form 4 filings.
See up to 3 months of APGE. The 7-day demo opens the 1M and 3M ranges and puts APGE on your watchlist.
Start 7-day demoLatest APGE insider trades
Carl Dambkowski - OfficerOpen-market sale$738K
Michael Thomas Henderson - OfficerOpen-market sale$2.67M
About Apogee Therapeutics, Inc. (APGE)
The SEC lists Apogee Therapeutics, Inc. under CIK 0001974640, in biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
APGE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 5,500 | $738K |
| Option exercise | 6 | 92,666 | |
| Bona-fide gift | 1 | 15,000 | |
APGE insider transactions (Form 4)
1166 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 6,665 | $46.07 | $307K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 13,328 | $46.50 | $620K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,672 | $47.19 | $79K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,326 | $58.91 | $314K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 1,339 | $59.96 | $80K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 14,000 | $59.17 | $828K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 1,000 | $59.94 | $60K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 5,740 | $56.16 | $322K | |
| Carl Dambkowski - Officer | Open-market sale | Common Stock | 925 | $56.86 | $53K | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 30,288 | $56.07 | $1.70M | |
| Michael Thomas Henderson - Officer | Open-market sale | Common Stock | 9,712 | $56.74 | $551K |
Recent APGE Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
APGE insider trading FAQ
What is the latest insider trade for APGE?
Apogee Therapeutics, Inc. (APGE) had 12 insider filings in the last 90 days, with the most recent on 2026-09-03. The full record for APGE runs to 66 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying APGE stock?
No insider purchases of APGE were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling APGE stock?
1 insider sale of APGE was filed in the last 90 days, totaling $738K.
Where can I see APGE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects APGE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Fairmount Funds Management LLC view on EDGAR
- - Mark C. McKenna view on EDGAR
- - William A. Jones Jr. view on EDGAR
- - Carl Dambkowski view on EDGAR
- - Jennifer A. Fox view on EDGAR
- - Jane Henderson view on EDGAR
- - Lisa Bollinger view on EDGAR
- - Michael Thomas Henderson view on EDGAR
- - Nimish P. Shah view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where APGE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow APGE with a 7-day demo
- APGE on your watchlist
- Every APGE Form 4 filing on record
- Up to 3 months of APGE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
